BPC-157

BPC-157 is a lab-made chain of 15 amino acids. Amino acids are the building blocks of proteins ^[6]. The name stands for Body Protection Compound. Its makers say it copies a short piece of a protein found in human stomach juice. A team in Croatia first wrote about it in 1993 ^[6]. It is also called bepecin and PL 14736. No FDA-approved drug contains it ^[6]. Online sellers, clinics and some pharmacies promote it for injury recovery, joint pain and gut health ^{[6] [14]}. It is sold as shots, capsules and nasal sprays. FDA says the name is used loosely. Products sold as BPC-157 can hold different forms of the peptide, so a buyer cannot be sure what they are getting ^[6].

BPC-157 is in limbo: FDA removed it from Category 2 in April 2026 and has not added it to Category 1 ^{[1] [2] [7] [9]}. That is not approval, and it does not make compounding lawful. FDA reviewed it for ulcerative colitis, a bowel disease, but it is sold mostly for recovery from injuries ^{[4] [6]}. Checked 23 October 2026.

Category 2 is FDA's list of substances that may present significant safety risks. Category 1 is the list of substances pharmacies may use while FDA reviews them ^[3]. FDA took BPC-157 off Category 2 because the groups that had nominated it pulled their nominations ^{[1] [7]}. On 23 July 2026, FDA's Pharmacy Compounding Advisory Committee voted 8 to 6, with 1 member abstaining, to recommend adding it to the list pharmacies may use ^{[5] [7] [19]}. FDA's own scientists had advised against this ^[6]. A committee vote is only advice ^[18]. FDA decides by writing a rule, and it has not proposed one ^{[7] [8]}.

Until then, a pharmacy that makes BPC-157 is outside federal law. FDA has warned a pharmacy for doing this ^[17]. Selling it for people to use is also illegal, even when the label says it is for research only ^[16].

The evidence grade is animal-only: the studies that show an effect used rats or cells, and no controlled trial in people has been published in full ^{[13] [6]}. In rats whose Achilles tendon was cut from the bone, shots of BPC-157 helped the tendon heal back onto the bone ^[11]. In rats whose colon lost its blood supply, BPC-157 put on the bowel helped blood flow return ^[10]. In rat tendon cells grown in a dish, BPC-157 helped the cells spread and move ^[12]. Most of these animal studies came from one research group in Croatia ^{[10] [11]}.

In people, the evidence is thin. In one small trial, people with ulcerative colitis got BPC-157 or a dummy treatment as an enema for two weeks. Only a short meeting summary was published, and FDA found it too unclear to show any benefit ^[6]. A 2026 review found three small studies in people, with 30 people in all and no comparison group. It rated the evidence as very low quality ^[13]. A safety study gave it by drip to two adults and found no problems, but two people are far too few to judge its risks ^[15]. The human studies so far are too small and too weak to show that the animal results carry over to people ^[13].

The only legal way to get BPC-157 in the US today is to join a clinical trial ^[22]. No approved drug contains it, here or in any other country ^[6]. A pharmacy may not make it under federal law. It has no official quality standard, it is not part of an approved drug, and it is not on the list pharmacies may use ^{[3] [17]}. That could change if FDA adds it by writing a rule after the committee vote. FDA has not proposed that rule ^[7].

On 24 October 2026 the official trial registry listed one US trial in Arkansas. It tests BPC-157 after shoulder surgery and is not yet recruiting ^[22]. Open trials are listed in the trials block below, with the date the registry was last checked. FDA found one early study of BPC-157 in healthy adults, registered in Mexico, with no results posted ^[6].

Most people who use BPC-157 get it in one of three ways ^[6]. The first is online sellers that label it for research use only. FDA says that label does not make it legal to sell a drug meant for people ^[16]. The second is pharmacies that make it even though it is not on the federal list. FDA has warned a pharmacy for doing this ^[17]. The third is clinics and medical spas that give it as shots ^[6].

In all three, nobody checks what is in the product the way FDA checks an approved drug. FDA says BPC-157 powder is poorly defined. The test sheets that come with it check purity, but not impurities or germs ^[6]. Reports of harm come from FDA's adverse event files and from news stories about people who say they got sick after using it ^{[6] [20]}. These reports cannot prove BPC-157 caused the harm. Nobody tracks how often harm happens.